Effective Jan. 19, 2025, the USPTO implemented a new fee framework for IDS submissions, charging up to $800 for applications that list more than 200 references. The change is aimed at curbing ...
Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company ...
Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...
The Indian Patent Office's decision to cancel the patent for Novartis's major heart drug, Vymada, has added a new chapter to ...
Patents in alternative proteins such as cultivated meat, plant-based meat and even insect protein are declining. Innovation ...
For applicants with a patent application having, or amended to have, a streamlined claim set—one independent claim and a maximum of nine ...
Welcome to the very first installment of Cool AI Patents of the Month. Each month, we’ll look at some of the more ...
The number of patents registered in a country is one benchmark of its scientific acumen and economic vitality. Around 1979, when Harvard Professor Ezra Vogel made the New York Times' bestseller list ...
RespireRx Pharmaceuticals Inc. ('RespireRx” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...
Company making progress toward eventual commercialization of the pump, which is designed for deployment in advanced small and ...
ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced regenerative health solutions, today announced the filing of a ...
You might also like Hyderabad Police Smash Massive Piracy Network, Blocking Rs 1.61 Cr Linked to iBomma Weekly Startup News: Everything From Funding Updates To IPO Buzz And Big-Deal Moves Weekly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback